| scholarly article | Q13442814 |
| P50 | author | Michel De Vos | Q57626462 |
| Panagiotis Drakopoulos | Q85588897 | ||
| P2093 | author name string | Herman Tournaye | |
| Nikolaos P Polyzos | |||
| Christophe Blockeel | |||
| Michel Camus | |||
| Dominic Stoop | |||
| P2860 | cites work | Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes | Q24240694 |
| Cycle regimens for frozen-thawed embryo transfer | Q24242737 | ||
| Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo | Q34101342 | ||
| Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization | Q35558375 | ||
| Multiple birth resulting from ovarian stimulation for subfertility treatment | Q36135826 | ||
| An OHSS-Free Clinic by segmentation of IVF treatment | Q37914493 | ||
| Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner | Q38495317 | ||
| ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria | Q39759151 | ||
| Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial | Q40254344 | ||
| Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy | Q41608397 | ||
| Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles | Q42166546 | ||
| High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol | Q44395927 | ||
| Can you ever collect too many oocytes? | Q44506206 | ||
| A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome | Q44957194 | ||
| Sub-optimal responders following controlled ovarian stimulation: an overlooked group? | Q48573197 | ||
| Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection | Q48593718 | ||
| Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles | Q48609705 | ||
| The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China | Q48620702 | ||
| GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients | Q48623268 | ||
| Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles | Q48673616 | ||
| A high oocyte yield for intracytoplasmic sperm injection treatment is associated with an increased chromosome error rate | Q48762964 | ||
| Optimum number of oocytes for a successful first IVF treatment cycle | Q50644397 | ||
| Correlation between number of retrieved oocytes and pregnancy rate after in vitro fertilization/intracytoplasmic sperm infection. | Q55035285 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 370-376 | |
| P577 | publication date | 2016-01-02 | |
| P1433 | published in | Human Reproduction | Q5937357 |
| P1476 | title | Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos? | |
| P478 | volume | 31 |
| Q90173547 | A clinical counseling tool predicting supernumerary embryos after a fresh IVF cycle |
| Q64230353 | Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment |
| Q48114898 | Association between the number of oocytes retrieved and cumulative live birth rate in women aged 35-40 years undergoing long GnRH agonist IVF/ICSI cycles. |
| Q92972687 | Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry |
| Q64060782 | Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders |
| Q48519953 | Cumulative live birth and surplus embryo incidence after frozen-thaw cycles in PCOS: how many oocytes do we need? |
| Q89842525 | Cumulative live birth rates according to the number of oocytes retrieved following the "freeze-all" strategy |
| Q64063042 | Cumulative live birth rates following a 'freeze-all' strategy: a population-based study |
| Q58769667 | Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why |
| Q89871757 | Does the presence of AGG interruptions within the CGG repeat tract have a protective effect on the fertility phenotype of female FMR1 premutation carriers? |
| Q90320261 | EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays |
| Q90630056 | Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer |
| Q33747432 | Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis. |
| Q37157543 | Elevated progesterone on the trigger day does not impair the outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone acetate treatment cycles |
| Q64990037 | Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure |
| Q42382813 | Excellence in assisted reproductive technologies: clinical and laboratory perspectives |
| Q88993307 | Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases-an analysis of 992 stimulations |
| Q48536542 | Freeze-all cycle for all normal responders? |
| Q91933047 | IVF outcomes of women with discrepancies between age and serum anti-Müllerian hormone levels |
| Q92712212 | Impact of Female Obesity on Cumulative Live Birth Rates in the First Complete Ovarian Stimulation Cycle |
| Q90219885 | Impact of Maternal Age on Oocyte and Embryo Competence |
| Q92106259 | In Freeze-All Strategy, Cumulative Live Birth Rate (CLBR) Is Increasing According to the Number of Blastocysts Formed in Women <40 Undergoing Intracytoplasmic Sperm Injection (ICSI) |
| Q52663984 | Individualized controlled ovarian stimulation in expected poor-responders: an update |
| Q57092079 | Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle |
| Q90400739 | Management Strategies for POSEIDON Groups 3 and 4 |
| Q91971401 | Management of Women With an Unexpected Low Ovarian Response to Gonadotropin |
| Q90293320 | New Twists in Ovarian Stimulation and Their Practical Implications |
| Q39034938 | New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. |
| Q90597789 | Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations |
| Q58576735 | Observational retrospective study of US national utilisation patterns and live birth rates for various ovarian stimulation protocols for in vitro fertilisation |
| Q90122087 | Outcomes of ovarian stimulation and fertility preservation in breast cancer patients with different hormonal receptor profiles |
| Q64236124 | Ovarian Sensitivity Index (OSI): Validating the Use of a Marker for Ovarian Responsiveness in IVF |
| Q92442735 | Ovarian stimulation modalities in poor responders |
| Q90587384 | Prediction of in vitro fertilization outcome at different antral follicle count thresholds combined with female age, female cause of infertility, and ovarian response in a prospective cohort of 8269 women |
| Q91796937 | Prediction of live birth and cumulative live birth rates in freeze-all-IVF treatment of a general population |
| Q52774809 | Pregnancy and obstetric outcomes of elective single versus double cleavage-stage embryo transfer |
| Q55344932 | Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Er |
| Q96303463 | Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF |
| Q52655165 | Successful preimplantation genetic diagnosis by targeted next-generation sequencing on an ion torrent personal genome machine platform |
| Q91868092 | The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists |
| Q64247339 | The incidence of unexpected poor ovarian response in Chinese young women |
| Q33830367 | The myths surrounding mild stimulation in vitro fertilization (IVF) |
| Q38602011 | Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health |
| Q64108087 | Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria |
| Q58606284 | Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index |
| Q98727205 | Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept |
| Q92188685 | Use of Cumulative Live Birth Rate per Total Number of Embryos to Calculate the Success of IVF in Consecutive IVF Cycles in Women Aged ≥35 Years |
Search more.